BR9700829A - Uso de interferon consensus humano para a produção de um medicamento - Google Patents
Uso de interferon consensus humano para a produção de um medicamentoInfo
- Publication number
- BR9700829A BR9700829A BR9700829A BR9700829A BR9700829A BR 9700829 A BR9700829 A BR 9700829A BR 9700829 A BR9700829 A BR 9700829A BR 9700829 A BR9700829 A BR 9700829A BR 9700829 A BR9700829 A BR 9700829A
- Authority
- BR
- Brazil
- Prior art keywords
- drug
- production
- human consensus
- consensus interferon
- interferon
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/595,440 US5980884A (en) | 1996-02-05 | 1996-02-05 | Methods for retreatment of patients afflicted with Hepatitis C using consensus interferon |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9700829A true BR9700829A (pt) | 1998-07-07 |
Family
ID=24383236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9700829A BR9700829A (pt) | 1996-02-05 | 1997-01-30 | Uso de interferon consensus humano para a produção de um medicamento |
Country Status (15)
Country | Link |
---|---|
US (1) | US5980884A (pt) |
EP (1) | EP0879059A1 (pt) |
JP (1) | JP2000504010A (pt) |
KR (1) | KR19990082084A (pt) |
CN (1) | CN1217660A (pt) |
AU (1) | AU1531897A (pt) |
BR (1) | BR9700829A (pt) |
CZ (1) | CZ231998A3 (pt) |
EA (1) | EA199800674A1 (pt) |
HU (1) | HUP9900929A3 (pt) |
IL (1) | IL125494A0 (pt) |
NO (1) | NO983410L (pt) |
SK (1) | SK101798A3 (pt) |
WO (1) | WO1997027866A1 (pt) |
ZA (1) | ZA97721B (pt) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA001147B1 (ru) * | 1996-02-28 | 2000-10-30 | ИФИ ИСТИТУТО ФАРМАКОТЕРАПИКО ИТАЛИАНО С.п.А. | Лекарственный препарат для терапевтического лечения вирусного гепатита |
MY164523A (en) | 2000-05-23 | 2017-12-29 | Univ Degli Studi Cagliari | Methods and compositions for treating hepatitis c virus |
EP1736478B1 (en) * | 2000-05-26 | 2015-07-22 | IDENIX Pharmaceuticals, Inc. | Methods and compositions for treating flaviviruses and pestiviruses |
AU2002227252A1 (en) * | 2000-12-01 | 2002-06-11 | Cornell Research Foundation | Animal model for flaviviridae infection |
US20050079579A1 (en) * | 2001-02-28 | 2005-04-14 | Guangwen Wei | Uses of spatial configuration to modulate protein function |
CN1245215C (zh) * | 2001-02-28 | 2006-03-15 | 四川省生物工程研究中心 | 重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂 |
US20060035327A1 (en) * | 2001-02-28 | 2006-02-16 | Guangwen Wei | Recombinant super-compound interferon and uses thereof |
US8551469B2 (en) * | 2001-02-28 | 2013-10-08 | Superlab Far East Limited | Treatment of tumors and viral diseases with recombinant interferon alpha |
EP1435997A4 (en) * | 2001-09-28 | 2006-03-01 | Intermune Inc | TECHNIQUE FOR TREATING HEPATITIS C VIRUS INFECTION FOR PATIENTS WHOSE TREATMENT FAILED |
PL369129A1 (en) * | 2001-09-28 | 2005-04-18 | Intermune, Inc. | Method for treating hepatitis c virus infection in treatment failure patients |
JP2005504087A (ja) * | 2001-09-28 | 2005-02-10 | イデニクス(ケイマン)リミテツド | 4’が修飾されたヌクレオシドを使用するc型肝炎ウイルス治療のための方法および組成物 |
KR20050030886A (ko) * | 2001-10-05 | 2005-03-31 | 인터뮨, 인크. | 다단계 인터페론 전달 프로필로 간염 바이러스 감염의 치료 방법 |
US20050013801A1 (en) * | 2001-10-05 | 2005-01-20 | Hsu Henry H. | Methods of treating liver fibrosis and hepatitis c virus infection |
JP2005517648A (ja) * | 2001-12-07 | 2005-06-16 | インターミューン インコーポレイテッド | 肝炎ウイルス感染症を治療するための組成物および方法 |
BR0307712A (pt) * | 2002-02-14 | 2005-05-24 | Pharmasset Ltd | Composto, composição e uso dos mesmos no tratamento de infecções por flaviviridae e proliferação celular anormal |
US20040063912A1 (en) * | 2002-03-15 | 2004-04-01 | The Brigham And Women's Hospital, Inc. | Central airway administration for systemic delivery of therapeutics |
US20030199464A1 (en) * | 2002-04-23 | 2003-10-23 | Silviu Itescu | Regeneration of endogenous myocardial tissue by induction of neovascularization |
US7608600B2 (en) | 2002-06-28 | 2009-10-27 | Idenix Pharmaceuticals, Inc. | Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections |
AU2003247084B9 (en) | 2002-06-28 | 2018-07-26 | Centre National De La Recherche Scientifique | Modified 2' and 3'-nucleoside prodrugs for treating flaviridae infections |
MXPA04012802A (es) | 2002-06-28 | 2005-04-19 | Idenix Cayman Ltd | Ester 2'-c-metil-3'-o-l-valina de ribofuranosil-citidina para el tratamiento de infecciones por flaviviridae. |
CN101172993A (zh) | 2002-06-28 | 2008-05-07 | 埃迪尼克斯(开曼)有限公司 | 用于治疗黄病毒感染的2′-c-甲基-3′-o-l-缬氨酸酯核糖呋喃基胞苷 |
MXPA05005192A (es) | 2002-11-15 | 2005-09-08 | Idenix Cayman Ltd | Nucleosidos ramificados en la posicion 2' y mutacion de flaviviridae. |
CA2509687C (en) | 2002-12-12 | 2012-08-14 | Idenix (Cayman) Limited | Process for the production of 2'-branched nucleosides |
US20070077225A1 (en) * | 2003-02-28 | 2007-04-05 | Blatt Lawrence M | Continuous delivery methods for treating hepatitis virus infection |
AU2003225670A1 (en) * | 2003-02-28 | 2004-09-28 | Intermune, Inc. | Interferon drug therapy for the treatment of viral diseases and liver fibrosis |
CN100503628C (zh) | 2003-05-30 | 2009-06-24 | 法莫赛特股份有限公司 | 修饰的氟化核苷类似物 |
US7585647B2 (en) * | 2003-08-28 | 2009-09-08 | Guangwen Wei | Nucleic acid encoding recombinant interferon |
SI1663110T1 (sl) * | 2003-08-28 | 2014-04-30 | Superlab Far East Limited | Uporaba interferonov s spremenjeno prostorsko strukturo |
AP2287A (en) | 2003-10-14 | 2011-10-31 | Intermune Inc | Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication. |
WO2005074650A2 (en) | 2004-02-02 | 2005-08-18 | Ambrx, Inc. | Modified human four helical bundle polypeptides and their uses |
WO2005107742A1 (en) | 2004-05-05 | 2005-11-17 | Yale University | Novel antiviral helioxanthin analogs |
CN101023094B (zh) | 2004-07-21 | 2011-05-18 | 法莫赛特股份有限公司 | 烷基取代的2-脱氧-2-氟代-d-呋喃核糖基嘧啶和嘌呤及其衍生物的制备 |
KR101177590B1 (ko) | 2004-09-14 | 2012-08-27 | 파마셋 인코포레이티드 | 2'-플루오로-2'-알킬 치환되거나 또는 다른 선택적으로치환된 리보퓨라노실 피리미딘 및 퓨린 및 그 유도체의제조 |
EP2537527A3 (en) * | 2005-03-09 | 2013-02-20 | Guangwen Wei | Uses of recombinant super-compound interferons |
EP2305695A3 (en) | 2005-07-25 | 2011-07-27 | Intermune, Inc. | Macrocyclic inhibitors of Hepatitis C virus replication |
CN101415705B (zh) | 2005-10-11 | 2011-10-26 | 因特蒙公司 | 抑制丙型肝炎病毒复制的化合物和方法 |
ES2422290T3 (es) | 2005-12-23 | 2013-09-10 | Idenix Pharmaceuticals Inc | Procedimiento para preparar un producto intermedio sintético para la preparación de nucleósidos ramificados |
US7964580B2 (en) | 2007-03-30 | 2011-06-21 | Pharmasset, Inc. | Nucleoside phosphoramidate prodrugs |
TW200946541A (en) * | 2008-03-27 | 2009-11-16 | Idenix Pharmaceuticals Inc | Solid forms of an anti-HIV phosphoindole compound |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
TW201031675A (en) | 2008-12-23 | 2010-09-01 | Pharmasset Inc | Synthesis of purine nucleosides |
US8551973B2 (en) | 2008-12-23 | 2013-10-08 | Gilead Pharmasset Llc | Nucleoside analogs |
AU2009329867B2 (en) | 2008-12-23 | 2015-01-29 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
TWI576352B (zh) * | 2009-05-20 | 2017-04-01 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
US8618076B2 (en) | 2009-05-20 | 2013-12-31 | Gilead Pharmasset Llc | Nucleoside phosphoramidates |
BRPI1012951A2 (pt) * | 2009-06-09 | 2016-07-26 | Defyrus Inc | "administração de interferon para profilaxia ou tratamento de infecção por patôgeno" |
WO2011014882A1 (en) | 2009-07-31 | 2011-02-03 | Medtronic, Inc. | CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF INTERFERON-α TO HEPATITIS C INFECTED PATIENTS |
HUE026235T2 (en) | 2010-03-31 | 2016-06-28 | Gilead Pharmasset Llc | Crystalline (S) -isopropyl 2 - (((S) - (((2R, 3R, 4R, 5R) -5- (2,4-dioxo-3,4-dihydropyrimidin-1 (2H) -IL) - 4-Fluoro-3-hydroxy-4-methyltetrahydrofuran-2-IL) methoxy) (phenoxy) phosphoryl) amino) propanoate |
US8563530B2 (en) | 2010-03-31 | 2013-10-22 | Gilead Pharmassel LLC | Purine nucleoside phosphoramidate |
US20120123338A1 (en) | 2010-06-16 | 2012-05-17 | Medtronic, Inc. | Damping systems for stabilizing medications in drug delivery devices |
TW201242974A (en) | 2010-11-30 | 2012-11-01 | Gilead Pharmasset Llc | Compounds |
US8466159B2 (en) | 2011-10-21 | 2013-06-18 | Abbvie Inc. | Methods for treating HCV |
CN104023726A (zh) | 2011-10-21 | 2014-09-03 | 艾伯维公司 | 用于治疗hcv的一种或多种daa的联合治疗(例如,与abt-072或abt-333) |
US8492386B2 (en) | 2011-10-21 | 2013-07-23 | Abbvie Inc. | Methods for treating HCV |
UY34402A (es) | 2011-10-21 | 2013-05-31 | Abbvie Inc | Métodos para el tratamiento de hcv |
US8889159B2 (en) | 2011-11-29 | 2014-11-18 | Gilead Pharmasset Llc | Compositions and methods for treating hepatitis C virus |
US8809354B2 (en) | 2011-12-31 | 2014-08-19 | Sheikh Riazuddin | 3-amino-2-(4-nitrophenyl)-4-(3H)-quinazolinone or derivatives thereof for treating or preventing antiviral infections |
TW201427681A (zh) | 2013-01-07 | 2014-07-16 | Superlab Far East Ltd | 用空間構象改變的重組干擾素治療腫瘤的方法 |
MX2016002185A (es) | 2013-08-27 | 2016-06-06 | Gilead Pharmasset Llc | Formulacion combinada de dos compuestos antivirales. |
US11192914B2 (en) | 2016-04-28 | 2021-12-07 | Emory University | Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6936694B1 (en) * | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
US5372808A (en) * | 1990-10-17 | 1994-12-13 | Amgen Inc. | Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect |
-
1996
- 1996-02-05 US US08/595,440 patent/US5980884A/en not_active Expired - Lifetime
-
1997
- 1997-01-13 IL IL12549497A patent/IL125494A0/xx unknown
- 1997-01-13 HU HU9900929A patent/HUP9900929A3/hu unknown
- 1997-01-13 AU AU15318/97A patent/AU1531897A/en not_active Abandoned
- 1997-01-13 SK SK1017-98A patent/SK101798A3/sk unknown
- 1997-01-13 KR KR1019980705806A patent/KR19990082084A/ko not_active Application Discontinuation
- 1997-01-13 CN CN97193506A patent/CN1217660A/zh active Pending
- 1997-01-13 EA EA199800674A patent/EA199800674A1/ru unknown
- 1997-01-13 CZ CZ982319A patent/CZ231998A3/cs unknown
- 1997-01-13 EP EP97901413A patent/EP0879059A1/en not_active Withdrawn
- 1997-01-13 WO PCT/US1997/000340 patent/WO1997027866A1/en not_active Application Discontinuation
- 1997-01-13 JP JP9527645A patent/JP2000504010A/ja active Pending
- 1997-01-29 ZA ZA9700721A patent/ZA97721B/xx unknown
- 1997-01-30 BR BR9700829A patent/BR9700829A/pt active Search and Examination
-
1998
- 1998-07-23 NO NO983410A patent/NO983410L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1217660A (zh) | 1999-05-26 |
AU1531897A (en) | 1997-08-22 |
CZ231998A3 (cs) | 1999-03-17 |
SK101798A3 (en) | 2000-03-13 |
EA199800674A1 (ru) | 1999-02-25 |
US5980884A (en) | 1999-11-09 |
NO983410D0 (no) | 1998-07-23 |
IL125494A0 (en) | 1999-03-12 |
JP2000504010A (ja) | 2000-04-04 |
NO983410L (no) | 1998-10-05 |
HUP9900929A3 (en) | 1999-11-29 |
HUP9900929A2 (hu) | 1999-07-28 |
ZA97721B (en) | 1997-08-01 |
EP0879059A1 (en) | 1998-11-25 |
KR19990082084A (ko) | 1999-11-15 |
WO1997027866A1 (en) | 1997-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9700829A (pt) | Uso de interferon consensus humano para a produção de um medicamento | |
CY2007001I1 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
PT864327E (pt) | Utilizacao de derivados de pirimidina para a preparacao de um medicamento para a prevencao do cancro | |
FI952932A0 (fi) | Monomeeriset insuliinianalogivalmisteet | |
DK0941103T3 (da) | Farmaceutisk præparat til behandling af diabetes | |
DE69525148T2 (de) | Pharmazeutische formulierung | |
DE69513671D1 (de) | Arzneimittel | |
MA26549A1 (fr) | Medicaments | |
NO954486D0 (no) | Farmasöytiske formuleringsgrunnlag | |
BR9701673A (pt) | Disposição para a aplicação de um líquido medicinal | |
NO982874D0 (no) | Farmas°ytiske preparater med vitamin D-analoger | |
FI964619A (fi) | Epilepsialääkkeiden iholle annostelu | |
BR9601193A (pt) | Vacina de múltiplos componentes e processos para preparar e administrar a vacina | |
DK0879054T3 (da) | Anvendelse af pyrrolidionderivater til fremstilling af medikamenter til behandling af narkotikamisbrug | |
FI973230A (fi) | Uusi farmaseuttinen formulaatio | |
FI951155A0 (fi) | Farmaseuttinen valmiste | |
HUP9904181A3 (en) | Sufrace-stabilised pharmaceutical preparation for application on the skin | |
EE200000401A (et) | Farmatseutilise preparaadi valmistamismeetod | |
NO942228D0 (no) | Ipsapiron-legemiddeltilberedning | |
FI953720A (fi) | Neurotensiiniantagonistien käyttö diureettietan lääkkeiden valmistamiseksi | |
LV11966A (lv) | Pretiekaisumu lidzeklis arigai lietosanai | |
DE69810442D1 (de) | Anordnung zur verabreichung von medikamenten | |
BR9603673A (pt) | Preparado de combinação farmacêutica compreendendo cetoprofeno | |
IT1295067B1 (it) | Uso di arsenico per preparare un medicamento per il trattamento della sindrome premestruale | |
DE29618094U1 (de) | Pharmazeutisches Präparat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB34 | Technical and formal requirements: requirement - article 34 of industrial property law | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |